A personal mission

A personal mission to make a difference

ProQR was founded in 2012 by our current CEO, Daniel de Boer. A few years earlier Daniel and his family were faced with the diagnosis of cystic fibrosis in his newborn son, an incurable rare genetic disease. Daniel sought help from experts in the field of drug development and formed ProQR to help people like his son.

Daniel de Boer, CEO of ProQR Therapeutics

Daniel de Boer, CEO

Daniel remains a passionate advocate for rare disease patients and is determined to make a difference in the world. Daniel continues to motivate ProQRians to remind them of the company’s mission and to always act in the interest of patients.

Biotech veterans

Biotech veterans

A group of experienced biotech entrepreneurs joined Daniel and ProQR was founded with co-founders Dinko ValerioGerard Platenburg and the late Henri A. Termeer.

Henri Termeer

Henri Termeer was a visionary rare disease leader that pioneered rare disease drug development as the CEO of Genzyme. In 2017, Henri unexpectedly passed away. ProQR continues to honor his legacy through our mission of helping people living with rare diseases who have no treatment options.

Henri Termeer

Henri Termeer

To learn more about Henri, visit the Henri Termeer Tribute website.

A dedicated team

A dedicated team

The drive and motivation that started the company is alive today. Engagement with the communities we serve is strong and so we work together to address the urgent need for new treatment options.